Intravenous Dolasetron for the Prevention of Postoperative Nausea and Vomiting After Outpatient Laparoscopic Gynecologic Surgery
- 1 February 1997
- journal article
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 84 (2), 325-330
- https://doi.org/10.1213/00000539-199702000-00015
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Dose-ranging evaluation of the serotonin antagonist dolasetron mesylate in patients receiving high-dose cisplatin.Journal of Clinical Oncology, 1994
- Acute Antiemetic Efficacy and Safety of Dolasetron Mesylate, A 5-HT3 Antagonist, in Cancer Patients Treated with CisplatinAmerican Journal of Clinical Oncology, 1994
- Risk factors for postoperative nausea and vomitingAnaesthesia, 1994
- Single oral dose ondansetron in the prevention of postoperative nausea and emesisAnaesthesia, 1994
- The effect of oral ondansetron in the prevention of postoperative nausea and vomiting after major gynaecological surgery performed under general anaesthesiaAnaesthesia, 1993
- Comparison of Ondansetron Versus Placebo to Prevent Postoperative Nausea and Vomiting in Women Undergoing Ambulatory Gynecologic SurgeryAnesthesiology, 1993
- Dolasetron mesylateDrugs of the Future, 1993
- Pharmacological properties of dolasetron, a potent and selective antagonist at 5‐HT3 receptorsDrug Development Research, 1993
- SPINAX ANAESTHESIA FOR CAESAREAN SECTIONBritish Journal of Anaesthesia, 1992
- Postoperative Nausea and VomitingAnesthesiology, 1992